Topigen Pharmaceuticals topigen.com


Public lists: Pharma Startups (4732)

Topigen is a biopharmaceutical company developing several new classes of drugs for respiratory disorders based upon its platform technology using DNARNA chemistry. These drugs are focused on inhibiting multiple inflammatory pathways at the cellular site of inflammation using a single drug product. Per the company, this approach has shown promising preclinical results in inhibiting the underlying inflammation associated with many pulmonary conditions such as asthma COPD and allergic rhinitis AR...Show all

Topigen is a biopharmaceutical company developing several new classes of drugs for respiratory disorders based upon its platform technology using DNARNA chemistry. These drugs are focused on inhibiting multiple inflammatory pathways at the cellular ...Show all

Company (Alive / Active)

Phone:

Fax:

2901 Rachel
Suite 13
Montreal, H1W 4A4
Quebec, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Topigen Pharmaceuticals $0M Nov 30, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Topigen Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
BDC Venture CapitalVenture CapitalMontreal, Quebec, CanadaOther Investors
CDP CapitalPrivate EquityMontreal, Quebec, CanadaOther Investors
Coller CapitalDebt & Specialty FinanceLondon, England, United KingdomOther Investors
Caisse de depot et placement du QuebecAsset/Investment ManagementQuebec City, Quebec, CanadaOther Investors
DesjardinsDiversified Financial ServicesMontreal, Quebec, CanadaOther Investors
See all 9 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antisense oligonucleotides for treating allergy and neoplastic cell proliferation Nov 21, 2011 Jun 19, 2012 Patent
Antisense oligonucleotides for treating allergy and neoplastic cell proliferation Oct 27, 2005 Feb 21, 2012 Patent
Oligonucleotides affecting expression of phosphodiesterases May 18, 2007 Jul 19, 2011 Patent